STOCK TITAN

Vanguard holds 6.59M shares of Guardant Health (NYSE: GH) — 5.02% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Vanguard Capital Management reported holding 6,589,394 shares of Guardant Health common stock, representing 5.02% of the class as of 03/31/2026. The filing shows sole dispositive power over 6,589,394 shares and sole voting power over 965,214 shares. The Schedule 13G form is signed by Ashley Grim as Head of Global Fund Administration on 04/30/2026.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 6,589,394 shares as of 03/31/2026
Percent of class 5.02% as of 03/31/2026
Sole voting power 965,214 shares reported voting power
Sole dispositive power 6,589,394 shares reported dispositive power
CUSIP 40131M109 Guardant Health common stock identifier
Signature date 04/30/2026 filing signed by Ashley Grim
Schedule 13G regulatory
"Name of issuer: Guardant Health Inc ... Schedule 13G filing"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned regulatory
"Amount beneficially owned: 6589394 (b) Percent of class: 5.02 %"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 6589394"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Investment Company Act regulatory
"investment companies registered under the Investment Company Act of 1940"
The Investment Company Act is a law that sets rules for businesses whose main activity is managing and selling pooled money, such as mutual funds and other investment funds. It matters to investors because it requires clear reporting, limits managers from putting their own interests ahead of clients, and mandates safekeeping and oversight of assets—similar to safety inspections and traffic rules that help keep shared vehicles reliable and trustworthy.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





40131M109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Capital Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/30/2026

FAQ

What stake does Vanguard Capital Management report in Guardant Health (GH)?

Vanguard Capital Management reports 6,589,394 shares, or 5.02%. The Schedule 13G lists ownership and voting/dispositive powers as of 03/31/2026, certified on 04/30/2026.

Does Vanguard have voting control over the reported Guardant Health shares?

Yes — the filing shows sole voting power for 965,214 shares. It also reports sole dispositive power over 6,589,394 shares and no shared voting or dispositive power.

Is the Vanguard stake held on behalf of other clients or funds?

Yes — holdings include Vanguard funds and managed accounts. The filing states the position reflects securities held by Vanguard funds and accounts over which Vanguard-affiliated entities exercise dispositive or voting power.

What date anchors the ownership percentage reported for Guardant Health?

The ownership percentage is tied to 03/31/2026. The Schedule 13G lists the 5.02% figure with that as-of date and the signature is dated 04/30/2026.

Who signed the Schedule 13G for Vanguard Capital Management?

The filing is signed by Ashley Grim, Head of Global Fund Administration. The signature date on the form is 04/30/2026.